An open study of B lymphocyte depletion in systemic lupus erythematosus.
about
Systemic lupus erythematosusB cells as a therapeutic target in autoimmune diseaseSLE - Rituximab in lupusCytokines in systemic lupus erythematosus, London, UKThe Autoimmune EcologyIn vivo, multimodal imaging of B cell distribution and response to antibody immunotherapy in miceCD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.B cell depletion in autoimmune disease.Management of therapy-resistant systemic lupus erythematosus with rituximab: report of a case and review of the literature.Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.Hematological disorders in patients with systemic lupus erythematosus.Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease.Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.Belimumab for the treatment of systemic lupus erythematosus.Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study.Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosusEfficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.Immunotherapy for autoimmune and inflammatory renal diseases.Treatment of severe proliferative lupus nephritis: the current state.B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experienceSafety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).Management of refractory systemic rheumatic diseases.The discovery and development of belimumab: the anti-BLyS-lupus connectionEfficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.Targeting B cells for the treatment of rheumatoid arthritisDoes B cell depletion have a role to play in the treatment of systemic lupus erythematosus?B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells.Cell therapy for autoimmune diseasesLupus nephritis: a review of the current pharmacological treatments.Prospects for B-cell-targeted therapy in autoimmune disease.B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response.Challenges in bringing the bench to bedside in drug development for SLE.
P2860
Q24543555-C0553217-110B-4EE3-B9B1-E50D77717192Q24804504-422B7E12-AED7-4BF5-9849-4AD36B18947DQ24804739-FE24438F-4C67-4ED9-8548-BCCA0ACF4E0EQ24804899-C21DCD5D-A25C-4853-B62B-548DAF6BEB4BQ26747427-FBE58956-6453-41CE-9A0C-8EF1DF6C4E65Q28752150-FCFBDCF3-604B-4C47-9A40-D7E973FEAE90Q30388433-5C79E67C-DA07-48C1-A110-E2F55B9049ABQ33360255-B0085FDF-3BBD-47B4-855E-152DBF9C0B2FQ33361142-8004F7D6-1501-4426-84C2-00F8794B0E59Q33367691-6EFCE27F-D977-4817-8050-4B0D1333E66FQ33387348-A96BED5D-4F84-45A6-9851-BFE2A7957AD2Q33401100-B384BC3C-E667-4F0E-8B60-3E945E3C3704Q33411323-A0FA5F79-7628-4485-81A5-8C51BA325C6AQ34063315-6A1CC217-FB9C-4886-99AF-526A5D154A38Q34085036-B7B1E7E5-9B30-45BC-8A9D-7495E64728A9Q34369159-66A2BA32-3374-4890-9175-33E466CD25EBQ34455827-7322F851-F09B-4922-8620-A68BC60A88BAQ34672043-5FB70BDA-7649-4850-A109-7EF32F81181AQ34781487-72DD898F-3854-467B-B943-8DDF2998D035Q34895937-F5D3CA96-A191-4BCB-AB9F-A338BE809CE8Q34897189-83864BC5-5BBD-425A-9ECB-D15DF8EEEC4DQ34897437-6632FBFB-7AF9-44BA-933D-175B7ECBFEEBQ35031692-5DEDE4F8-C11F-427B-80E1-2F6CB460E0BAQ35102984-2C39BCA2-BE91-44EF-B536-59EB3DCB9BABQ35144046-3897A68D-3E08-4F8C-96CA-D5EA66CFA8B7Q35201234-998CF807-5B07-4A2E-82DD-BF50DFB67B42Q35553501-44D22D09-D609-4214-B3F3-944EA0CFCAD0Q35557832-7F793D64-374B-4483-BC8D-6F9D80E390EDQ35640956-5066F158-89F8-4368-A554-FEA4ADAEE31AQ35691272-C3D1D8C6-BCEB-45CD-B8D9-32B56576E5A0Q35760171-65068F5B-A06D-4DF5-ACE2-2AFC93E0EE2DQ35761089-E0C9D4F8-30FB-4389-BE11-303119BB2C57Q35794365-AFE4405A-CB0F-45E4-A28E-BAB7324F9C3FQ35824478-C6DF7B77-DD4C-48EE-824A-6998C369990AQ35824525-368F9990-4DC7-4AF9-8D15-B2A8ABB6312BQ35868954-74467336-06F0-4A1A-A74F-65DA09203957Q35925513-7F85BACB-95B2-4444-9A3A-5F9F83EAF364Q35930307-DBBA9844-7BC1-41C1-9669-DF96C48F7B48Q35954653-E66C2F28-3470-4674-8A60-DD6DE0997390Q35968394-D995A172-54C5-4EDF-8FD3-4872F7784015
P2860
An open study of B lymphocyte depletion in systemic lupus erythematosus.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
An open study of B lymphocyte depletion in systemic lupus erythematosus.
@en
An open study of B lymphocyte depletion in systemic lupus erythematosus.
@nl
type
label
An open study of B lymphocyte depletion in systemic lupus erythematosus.
@en
An open study of B lymphocyte depletion in systemic lupus erythematosus.
@nl
prefLabel
An open study of B lymphocyte depletion in systemic lupus erythematosus.
@en
An open study of B lymphocyte depletion in systemic lupus erythematosus.
@nl
P2093
P2860
P356
P1476
An open study of B lymphocyte depletion in systemic lupus erythematosus.
@en
P2093
Geraldine Cambridge
Jonathan C Edwards
Maria J Leandro
P2860
P304
P356
10.1002/ART.10541
P577
2002-10-01T00:00:00Z